Inactive Instrument

News Pfizer Inc Nyse

Equities

End-of-day quote Nyse Other stock markets
- ^USD	-

Apr. 30	Pfizer, Genmab Say FDA Approves Tivak to Treat Cervical Cancer	MT
Apr. 30	A flurry of corporate results ahead of the Fed's rate decision

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pfizer : Goes Live in SXSW’s Podcast Lounge	Apr. 30	PU
Pfizer, Genmab Say FDA Approves Tivak to Treat Cervical Cancer	Apr. 30	MT
A flurry of corporate results ahead of the Fed's rate decision	Apr. 30
Sensodyne maker Haleon to shut UK factory with loss of 435 jobs	Apr. 30	AN
Genmab, Pfizer Win US FDA Approval for Cervical Cancer Treatment	Apr. 29	MT
TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer	Apr. 29	BU
FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer	Apr. 29	BU
Pfizer Inc. and Genmab A/S Announce FDA Grants Full Approval for TIVDAK to Treat Recurrent or Metastatic Cervical Cancer	Apr. 29	CI
J&J, Bristol Myers lose challenges to US drug price negotiation program	Apr. 29	RE
Pfizer, Genmab Get Full FDA Approval for Cervical-Cancer Drug	Apr. 29	DJ
Tesla Rally Boosts S&P 500, Nasdaq; This Week's Earnings, Fed Decision in Focus	Apr. 29	MT
Equity Markets Rise With Key Earnings, Fed Decision in Focus	Apr. 29	MT
US FDA grants full approval for Pfizer's cervical cancer drug	Apr. 29	RE
Equities Higher as Traders Await This Week's Key Earnings, Fed Decision	Apr. 29	MT
S&P 500 Companies' Latest Quarterly Results Mixed so Far, Oppenheimer Says	Apr. 29	MT
Equities Rise Intraday as Traders Await This Week's Key Earnings, Fed Decision	Apr. 29	MT
CAC40: limited downturn, despite the beginnings of a rate cut	Apr. 29	CF
Novel haemophilia B gene therapy approved	Apr. 29	AQ
CAC40: limited erosion, despite the beginnings of a rate cut	Apr. 29	CF
Declaration of Voting Results by Pfizer Inc	Apr. 29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Pfizer, Inc: A cycle for nothing?

December 14, 2023 at 10:58 am EST

Albert Bourla, Pfizer CEO (full interview): mRNA, acquisitions, weight-loss drugs

October 31, 2023 at 04:50 pm EDT